PER-067-02已完成未知
RANDOMIZED, DOUBLE-BLIND STUDY, CONTROLLED BY ACTIVE COMPARATOR IN PARALLEL GROUPS TO EVALUATE THE SAFETY OF ETORICOXIB IN PATIENTS WITH OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS.
MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2003年4月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The patient is male or female, is> 50 years of age, and a diagnosis
- •of osteoarthritis or rheumatoid arthritis that, in the opinion of the researcher,
- •will require chronic therapy of NSAIDs or selective COX-2 inhibitor by
- •minus 1.5 year.
排除标准
- •The patient is diagnosed as functional Class IV of the American
- •College of Rheumatology (ACR).
- •The patient has a concurrent medical or arthritic disease that could
- •confuse or interfere with the evaluation of effectiveness.
研究者
相似试验
已完成
不适用
RANDOMIZED, DOUBLE-BLIND STUDY, CONTROLLED WITH ACTIVE COMPARATOR, OF PARALLEL GROUPS, CARRIED OUT UNDER INTERNAL BLIND CONDITIONS TO EXAMINE THE SAFETY, TOLERABILITY AND EFFECTIVENESS OF 2 DOSE OF APPRENTICATOR IN THE PREVENTION OF NAUSEA AND POST-OPERATIVE VOMITINGPER-020-04MERCK SHARP & DOHME PERU S.R.L.,
已完成
不适用
A DOUBLE-BLIND, RANDOMIZED STUDY CONTROLLED WITH ACTIVE COMPARATOR MK-0767 AND METFFORMINA IN PATIENTS THAT SUFFER FROM DIABETES TYPE 2 INAPPROPRIATE CONTROL OF DIET AND EXERCISES.-E119 Non-insulin-dependent diabetes mellitus, without complicationsNon-insulin-dependent diabetes mellitus, without complicationsE119PER-065-03MERCK & CO.INC.,
进行中（未招募）
1 期
Estudio randomizado, doble ciego, controlado frente a placebo, prospectivo, multicéntrico, de búsqueda de dosis, en fase II/III, con atacicept subcutáneo en sujetos que recientemente han experimentado un brote de Lupus eritematoso sistémico.A randomised, double-blind, placebo-controlled, multicentre prospective dose-finding Phase II/III study with atacicept given subcutaneously to subjects having recently experienced a flare of systemic lupus erythematosus (SLE) - Atacicept in generalised SLE Phase II/IIIEUCTR2007-003698-13-ESMerck Serono International SA, An affiliate of Merck KGaA, Darmstadt, Germany
已完成
不适用
A DOUBLE BLIND STUDY, RANDOMIZED, CONTROLLED WITH ACTIVE CONTROLLER, MULTICENTER, PARALLEL GROUP, TEST OF CONCEPT OF L-454560 IN PATIENT WITH COPD.PER-021-03MERCK SHARP & DOHME PERU S.R.L.,
进行中（未招募）
不适用
A STUDY OF THE MAINTENANCE OF EFFICACY OF ETANERCEPT PLUS DMARD(S)COMPARED WITH DMARD(S) ALONE IN SUBJECTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING AN ADEQUATE RESPONSE WITHETANERCEPT PLUS DMARD(S)Rheumatoid ArthritisEUCTR2011-005448-87-HUPfizer Inc, 235 East 42nd Street, New York, NY 10017320